SEC Form 4 · accession 0001179110-17-001736
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Paul Bisaro
Officer — Exec Chairman · Director
Period of report
Feb 1, 2017
Accepted (ET)
Feb 3, 2017 · 8:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001 | Feb 1, 2017 | A | 7,105 | $229.32 | A | 188,867 | D | |
| Ordinary Shares, par value $0.0001F1 | Feb 1, 2017 | F | 3,411 | $229.32 | D | 185,456 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F2 | $229.32 | Feb 1, 2017 | C | 7,105 | D | Feb 1, 2017 | Feb 1, 2017 | Ordinary Shares | 7,105 | 0 | D |
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
- F2Represents performance-based restricted share units ("PSUs") which vested on February 1, 2017, following certification of achievement by issuer of certain performance criteria. Each PSU represented a contingent right to receive ordinary shares of the Issuer equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and Reporting Person.